Research & Development



  雲瑯一臉的堅毅之色,一個字都不說。   甦稚無所謂的道︰“女人是趙王太子丹的妃子,那個女人的兄長叫做江充!”我要爱久久影视   劉據從巨盾的縫隙里露出腦袋道︰“將軍辛苦,大軍繼續向前十里扎營。”深爱五月最新网站   雲瑯有些驚愕,又有些惶恐,小聲問道︰“你跟小喬覺得對不起我?”   儒門雖然還有瑕疵,即便是有瑕疵,他卻對國朝的大一統有著無法比擬的作用。尽情深爱网   雲瑯有些驚愕,又有些惶恐,小聲問道︰“你跟小喬覺得對不起我?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo